Our results, while confirming the fundamental role of TP53 annotations in MCL [8,33], which are well known to affect survival endpoints [33,34] and responses to treatments in MCL patients [35,36], shift attention to the need to reconsider the important role of CNVs in this disease. This evidence concerns the gene TP53 and mantle cell lymphoma.